Yoshiyuki Matsui - Concepedia

Author

Yoshiyuki Matsui

Also Known As

Eijiro Nakamura, Matsui, Y., Takahiro Kojima, Toshinari Yamasaki, Y Matsui, Y. Matsui, YOSHIYUKI MATSUI, Yoshinori Matsui, Yoshiyuki MATSUI, Yoshiyuki Matsui

291

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Kyoto University Kurashiki Central Hospital Tokyo National Hospital Tohoku University University of Tsukuba

About

Yoshiyuki Matsui is an author at Kyoto University specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	34	1.2K
2	Health Sciences	5	5	156
3	Public Health	2	2	33
4	Education	1	1	26
5	Anatomy	1	1	11

Yoshiyuki Matsui

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract Yoshiyuki Matsui, Noriaki Utsunomiya, Kentaro Ichioka, Urology UrologyCancer RiskGenitourinary CancerMedicinePathology	2005	161
Prevalence of and risk factors for nocturia: Analysis of a health screening program Koji Yoshimura, Naoki Terada, Yoshiyuki Matsui, International Journal of Urology	2004	147
Nocturia and benign prostatic hyperplasia Koji Yoshimura, Hiroki Ohara, Kentaro Ichioka, Urology Benign Prostatic HyperplasiaUrologyProstatic Disease	2003	115
EMERGENCY DRAINAGE FOR UROSEPSIS ASSOCIATED WITH UPPER URINARY TRACT CALCULI Koji Yoshimura, Noriaki Utsunomiya, Kentaro Ichioka, The Journal of Urology	2005	115
Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer Joong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, JNCI Journal of the National Cancer Institute	2010	108
Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer Hiroaki Kawanishi, Yoshiyuki Matsui, Masaaki Ito, Clinical Cancer Research	2008	106
Development of a Multiplex RNA Urine Test for the Detection and Stratification of Transitional Cell Carcinoma of the Bladder Andrew Holyoake, P.J. O’Sullivan, Rob Pollock, Clinical Cancer Research	2008	86
Demethylating Agent 5-Aza-2′-Deoxycytidine Enhances Susceptibility of Bladder Transitional Cell Carcinoma to Cisplatin Donghao Shang, Yuting Liu, Yoshiyuki Matsui, Urology UrologyOncologyGenitourinary CancerMedicineCancer Cell Biology	2008	81
Thioredoxin-interacting protein suppresses bladder carcinogenesis Koji Nishizawa, Hiroyuki Nishiyama, Yoshiyuki Matsui, Carcinogenesis	2011	77
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab Takashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, Cancer Science UrologyGenitourinary CancerChemoresistant Urothelial CancerUrothelial CarcinomaImmune Checkpoint Inhibitors	2020	72

Page 1